acadesine has been researched along with Fatty Liver, Nonalcoholic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, L; Hao, S; Sun, H; Wang, Z; Yu, P; Zhang, M; Zhang, X | 1 |
| Li, X; Lin, M; Men, J; Wang, Q; Yuan, Y; Zhang, M | 1 |
2 other study(ies) available for acadesine and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Synthesis of natural 3'-Prenylchalconaringenin and biological evaluation of ameliorating non-alcoholic fatty liver disease and metabolic syndrome.
Topics: 3T3-L1 Cells; AMP-Activated Protein Kinases; Animals; Chalcones; Chemistry Techniques, Synthetic; Hep G2 Cells; Humans; Metabolic Syndrome; Mice; Non-alcoholic Fatty Liver Disease; Signal Transduction; Stereoisomerism | 2020 |
The Chinese medicine Chai Hu Li Zhong Tang protects against non-alcoholic fatty liver disease by activating AMPKα.
Topics: Acetyl-CoA Carboxylase; Alanine Transaminase; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Aspartate Aminotransferases; Bupleurum; Cholesterol, HDL; Cholesterol, LDL; Drugs, Chinese Herbal; Gene Expression Regulation; Hep G2 Cells; Humans; Medicine, Chinese Traditional; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Rats; Ribonucleosides; Sterol Regulatory Element Binding Protein 2; Triglycerides | 2018 |